UNI-494 drug Mechanism of Action
Unicycive Therapeutics is focused on development of approaches to treat kidney diseases. One of the companies key technologies targets mitochondrial damage or dysfunction that contributes critically to the pathogenesis of various kidney diseases.
Project Goal
The Process
Between the production stages, we send all crucial information to our clients for review, giving them complete control over the final product. This approach significantly limits the average client time commitment, totaling only several hours for review and communication with the Visual Science team.
Our production and account management teams' deep scientific expertise prevents our clients from having to give detailed instructions or spend hours explaining their requirements to achieve industry-leading animation quality and scientific accuracy.
Why did we use this animation type?
For this MoA animation, we utilized our "Main 3D" animation type, which is the gold standard for such projects. It's one of the most popular options of the four main types and 25 variations we offer, designed to cater to various audiences, business goals, company stages, timeframes, and budgets.
We visualized the UNI-494 mechanism of action without going into the details of complex molecular interactions. This approach allowed us to develop a short, comprehensive, and well-balanced animation that provides an essential overview of the topic in an eye-catching format, effectively holding the audience's attention.
Full animation
or ask your question via [email protected]
